USANA Health Sciences Inc
$ 19.91
0.20%
12 Jun - close price
- Market Cap 367,599,000 USD
- Current Price $ 19.91
- High / Low $ 20.25 / 19.84
- Stock P/E 39.82
- Book Value 29.45
- EPS 0.50
- Next Earning Report 2026-07-28
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.04 %
- ROE 0.02 %
- 52 Week High 38.32
- 52 Week Low 16.60
About
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company is headquartered in Salt Lake City, Utah.
Analyst Target Price
$39.00
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-05 | 2026-02-17 | 2025-10-21 | 2025-07-22 | 2025-04-22 | 2025-02-25 | 2024-10-22 | 2024-07-23 | 2024-04-30 | 2024-02-06 | 2023-10-24 | 2023-07-25 |
| Reported EPS | 0.61 | 0.6 | -0.36 | 0.74 | 0.73 | 0.64 | 0.56 | 0.54 | 0.86 | 0.87 | 0.59 | 0.89 |
| Estimated EPS | 0.4 | 0.4 | 0.56 | 0.54 | 0.7 | 0.49 | 0.49 | 0.65 | 0.69 | 0.52 | 0.64 | 0.7 |
| Surprise | 0.21 | 0.2 | -0.92 | 0.2 | 0.03 | 0.15 | 0.07 | -0.11 | 0.17 | 0.35 | -0.05 | 0.19 |
| Surprise Percentage | 52.5% | 50% | -164.2857% | 37.037% | 4.2857% | 30.6122% | 14.2857% | -16.9231% | 24.6377% | 67.3077% | -7.8125% | 27.1429% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-07-28 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.43 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: USNA
2026-06-08 21:40:56
USANA Health Sciences' Chief People Officer, Paul A. Jones, sold 5,561 shares of the company's common stock at $18.50 per share in an open-market transaction. Following this sale, Jones no longer holds any direct shares in USANA. This transaction, categorized as a moderate impact with negative sentiment, was reported via a Form 4 filing.
2026-06-08 20:39:41
Paul A. Jones reported a sale of 6,813 shares of USANA Health Sciences (USNA) common stock on May 28, 2026, for $129,106.35, with Morgan Stanley Smith Barney LLC acting as the broker. The Form 144 filing also details three restricted stock issuances from the issuer in February 2026, totaling 5,561 shares. This transaction is categorized as a routine transfer and sale disclosure.
2026-06-08 18:39:41
USANA Health Sciences, Inc. has been recognized at The Beauty Awards Canada for its Celavive Contouring Face & Neck Crème, which was named Best Neck & Décolleté Cream of 2026. The product was praised for its innovative science, including ingredients like Feminage, BioPeptide-CS, Olivol24, and antioxidants, designed to promote skin elasticity and a youthful complexion. This prestigious award highlights Celavive's standing among Canada's top beauty products, especially in a challenging skincare category.
2026-06-08 10:39:41
USANA Health Sciences announced that its Celavive Contouring Face & Neck Crème won in the Best Neck & Décolleté Cream category at The Beauty Awards Canada. This recognition highlights the product's innovative science and luxurious experience, helping visibly lift, firm, and smooth skin. The crème is specifically designed for women aged 35 and older, featuring clinically studied ingredients like Feminage and BioPeptide-CS.
2026-06-05 21:40:15
USANA Health Sciences (USNA) reported Q1 2026 earnings per share of $0.61, significantly surpassing the forecast of $0.40, and revenue of $250 million, exceeding the expected $240.95 million. The company's stock price increased by 2.6% following the announcement, reflecting investor confidence in its strategic transformation to an omnichannel health and wellness platform. USANA reaffirmed its full-year 2026 net sales guidance and highlighted strong performance in its core nutritional business, as well as growth in its Hiya and Rise Wellness segments.
2026-06-04 11:09:09
USANA (NYSE:USNA) has earned two 2026 Best of State awards in Utah, specifically for its CellSentials dietary supplements and its Research and Development team. This marks the tenth consecutive year CellSentials has won the Dietary Supplement award and the eighth time for the R&D team, contributing to USANA's total of over 900 awards since 1992. These awards recognize the company's commitment to scientific rigor, innovation, and quality in its product development.
